Integra Lifesciences I v. Merck Kgaa. ( 2005 )


Menu:
  • Error: Bad annotation destination
    United States Court of Appeals for the Federal Circuit
    02-1052, -1065
    INTEGRA LIFESCIENCES I, LTD. and THE BURNHAM INSTITUTE,
    Plaintiffs-Cross Appellants,
    and
    TELIOS PHARMACEUTICALS, INC.,
    Plaintiff-Appellee,
    v.
    MERCK KGaA,
    Defendant-Appellant,
    and
    THE SCRIPPS RESEARCH INSTITUTE and DR. DAVID A. CHERESH,
    Defendants.
    Donald R. Dunner, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of
    Washington, DC, argued for defendant-appellant Merck KGaA. With him on the brief were
    Thomas H. Jenkins, David A. Manspeizer, and Rachel H. Townsend. Of counsel on the brief
    were M. Patricia Thayer, Heller Ehrman White & McAuliffe, LLP, of San Francisco, California;
    and William C. Rooklidge, Howrey Simon Arnold & White, LLP, of Irvine, California. Of
    counsel was Esther H. Lim, Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P., of
    Washington, DC.
    Mauricio A. Flores, Campbell & Flores LLP, of San Diego, California, argued for
    plaintiffs-cross appellants Integra LifeSciences I, Ltd. and The Burnham Institute. With him
    on the brief was David M. Beckwith. Of counsel on the brief were Raphael V. Lupo, Mark G.
    Davis, and Natalia V. Blinkova, McDermott, Will & Emery, of Washington, DC. Of counsel
    was Donna M. Tanguay.
    Appealed from:      United States District Court for the Southern District of California
    Senior Judge James M. Fitzgerald, District of Alaska
    United States Court of Appeals for the Federal Circuit
    02-1052, -1065
    INTEGRA LIFESCIENCES I, LTD. and THE BURNHAM INSTITUTE,
    Plaintiffs-Cross Appellants,
    and
    TELIOS PHARMACEUTICALS, INC.,
    Plaintiff-Appellee,
    v.
    MERCK KGaA,
    Defendant-Appellant,
    and
    THE SCRIPPS RESEARCH INSTITUTE and DR. DAVID A. CHERESH,
    Defendants.
    Before NEWMAN, RADER, and PROST, Circuit Judges.
    ORDER
    The court has received a certified copy of the judgment from the Clerk of the
    Supreme Court of the United States in Merck KGaA v. Integra Lifesciences I, Ltd., No. 03-
    1237. The Supreme Court vacated this court's judgment, which was reported at 
    331 F.3d 860
     (Fed. Cir. 2003), and remanded for proceedings consistent with the Court's opinion.
    Upon consideration thereof,
    IT IS ORDERED THAT:
    (1)    The mandate is hereby recalled and the appeal is reinstated.
    (2)    The case is returned to the original merits panel.
    (3)    New briefs shall be filed, with particular attention paid to the Supreme Court
    decision.
    (4)    The appellants' principal brief shall be due within 60 days of the date of filing
    of this order. The dates for filing the remaining briefs shall be in accordance with Fed. Cir.
    R. 31(a). An original and 22 copies of all briefs shall be filed, and two copies shall be
    served on opposing counsel. The court sua sponte allows amicus briefs.
    FOR THE COURT
    _Aug 17 2005__                                 _s/Jan Horbaly_____
    Date                                        Jan Horbaly
    Clerk
    cc:    Donald R. Dunner, Esq.
    Mauricio A. Flores, Esq.
    02-1052, -1065                                2
    

Document Info

Docket Number: 2002-1052

Filed Date: 8/17/2005

Precedential Status: Precedential

Modified Date: 12/21/2014